India's plan for barcodes to track drugs gathers pace

India flag
Pharmacy

The Drug Controller General of India (DGCI) is pushing for all drugs sold at the retail level to be barcode scanned as part of an effort to counter fake or substandard drugs that would cover imports and local manufacture.

The International Business Times, citing a story from India Abroad News Service, quoted DCGI chief G.N. Singh as saying plans for a barcode system in India are moving along. "Documents and the entire plan is with the ministry and they are examining it," Singh said, according to the reports. "This will be a technology-driven system."

The U.S. and European Union already require Indian manufacturers to barcode primary packages sent for export, but the move has been resisted domestically because of the cost for smaller firms. At the same time, India has struggled with continued fakes and poorly manufactured products at the retail level with no effective tracking mechanism as mom-and-pop pharmacies also cite the burdens of cost and equipment needed.

Whitepaper

Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.

The effort may also bring into sharper focus a running battle between upstart online drug retailers in India who face pressure to curb or halt sales by industry groups representing hundreds of thousands of small pharmacies. The new entrants say they have the technology to easily track products and deliveries in ways that will curb so-called spurious drugs.

India has previously said a domestic track-and-trace effort was in the works to grow alongside the one required for exporters that would feed data into a central portal. But the plans have so far not moved from the drawing board. In neighboring China, a track-and-trace system for drugs was derailed earlier this year as online retailers complained that the software designed by a unit of e-commerce giant Alibaba Group ($BABA) gave the firm an unfair advantage in gathering data.

- here's the story from the International Business Times

Related Articles:
Fledgling online pharmacies in India fight brick-and-mortar opponents
Indian drug regulator tags 200 firms for inspection on poor manufacturing quality
India seeks to move bar-code tracking on drugs further upstream

Read more on

Suggested Articles

Saturday, AstraZeneca revealed more of the data that convinced the FDA to green-light Calquence in previously untreated chronic lymphocytic leukemia.

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.